Company intelligence / Profile preview
NeuroScientific
Perth, Western Australia, Australianeuroscientific.com ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
01
Overview
NeuroScientific Biopharmaceuticals is an Australian drug development company focused on developing peptide-based therapeutics for neurodegenerative conditions and ocular diseases. The company's lead candidate, EmtinB, is a synthetic peptide derived from the active domain of the human protein metallothionein-II, designed to stimulate tissue repair and provide neuroprotection. EmtinB targets the LRP1 receptor to activate intracellular signaling pathways that promote neuronal survival and axonal regeneration. NeuroScientific is currently advancing its pipeline through clinical trials for indications such as Alzheimer's disease and glaucoma.
- Therapeutic areas
- OphthalmologyNeurology
- Modalities
- PeptidesBiologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Lions Eye InstituteUniversity of Western Australia
Beyond the preview
Go deeper on NeuroScientific.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeuroScientific.